Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

GL Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 81
Average round size
info
The average size of a deal this fund participated in
$72M
Portfolio companies 67
Rounds per year 11.57
Lead investments 17
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Information Technology
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of GL Ventures:
Typical Co-investors
GL Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after GL Ventures:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Acceleris Capital England, Manchester, United Kingdom
Cantor Jungle China, Shanghai
Cobalt (Life & Health Insurance) -
Danbei Qiye China, Ningbo, Zhejiang
Elevate Sports -
Fagor Electronica -
Founders Committee New York, New York, United States
Korea Thrunet Co Seoul, Seoul-t'ukpyolsi, South Korea
London Business Angels (LBA) England, London, United Kingdom
METRO Accelerator -
MicroPort Orthopedics Arlington, Tennessee, United States
Milestone Merchant Partners District of Columbia, United States, Washington
Mind the Seed - MTS Fund California, San Francisco, United States
Minzhu Capital China, Minhang, Shanghai
Quest Software Aliso Viejo, California, United States
Rockaway Capital Czech Republic, Prague, Prague
seedchange California, San Francisco, United States
TA Telecom Al Qahirah, Cairo, Egypt
TE Connectivity Schaffhausen, Schaffhausen, Switzerland
Velos Partners California, Los Angeles, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Feynman Dynamics

$15M07 Feb 2024 Tianjin, Tianjin, China

BayOmics

Biopharma
Biotechnology
Pharmaceutical
28 Jun 2023 Shenzhen, Guangdong, China

CoJourney

Biopharma
Health Care
Medical
Pharmaceutical
$30M27 Jun 2023 Hangzhou, Zhejiang, China

Kingwills New Materials

Advanced Materials
Manufacturing
$15M18 May 2023 Shanghai, Shanghai, China

AutoCore

Artificial Intelligence
Autonomous Vehicles
Intelligent Systems
Product Research
15 May 2023 Nanjing, Jiangsu, China

Tripod Preclinical Research Laboratories

Biopharma
Pharmaceutical
$5M12 Apr 2023 Nanjing, Jiangsu, China

ZD Power

Energy
Power Grid
$15M27 Oct 2022 -

Huiye Technology

Artificial Intelligence
10 Oct 2022 Haidian, Beijing, China

Airgram

Translation Service
$10M19 Aug 2022 -
News
IASO Biotherapeutics Secures $108 Million Series C Funding to Advance Global Development of Innovative Cell Therapies

– IASO Biotherapeutics announced the completion of $108m Series C to advance the global development of novel cell therapies and biologics for oncology and autoimmune diseases.
– The round was led by CDH Baifu, and followed by CCB International, with strong participation from Everbright Limited, Co-Stone Capital, CNCB Capital and Plaisance Capital.
– Current shareholder GL Ventures also participated.
– Since its founding in 2017, IASO Bio has raised more than $178m.
– Proceeds from the financing will be used to accelerate the global development and regulatory submissions of multiple novel cell therapies.

Agile Robots Closes US$220M Series C Financing

– Agile Robots from Munich, Germany and Beijing, China develops intelligent robotics.
– The company completed a Series C financing with a total investment of US$220m.
– The round was led by SoftBank Vision Fund 2 with participation from GL Ventures, Sequoia China and Linear Capital, and strategic investors including Xiaomi Group, Foxconn Industrial Internet, and Midas.
– Proceeds from the round will be mainly used for the company’s product development, mass production and global sales business expansion.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent GL Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 81
Average round size 72M
Rounds per year 11.57
Peak activity year 2021
Lead investments 17
Follow on index 0.12
Group Appearance index 0.96

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Feynman Dynamics

$15M07 Feb 2024 Tianjin, Tianjin, China

BayOmics

Biopharma
Biotechnology
Pharmaceutical
28 Jun 2023 Shenzhen, Guangdong, China

CoJourney

Biopharma
Health Care
Medical
Pharmaceutical
$30M27 Jun 2023 Hangzhou, Zhejiang, China

Kingwills New Materials

Advanced Materials
Manufacturing
$15M18 May 2023 Shanghai, Shanghai, China

AutoCore

Artificial Intelligence
Autonomous Vehicles
Intelligent Systems
Product Research
15 May 2023 Nanjing, Jiangsu, China

Tripod Preclinical Research Laboratories

Biopharma
Pharmaceutical
$5M12 Apr 2023 Nanjing, Jiangsu, China

ZD Power

Energy
Power Grid
$15M27 Oct 2022 -

Huiye Technology

Artificial Intelligence
10 Oct 2022 Haidian, Beijing, China

Airgram

Translation Service
$10M19 Aug 2022 -
Crunchbase icon

Content report

The following text will be sent to our editors: